[A05-20A] Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Final report version 1.1 (Erratum): Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Executive summary of the final report: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Final report: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Documentation and appraisal of comments on the preliminary report: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Preliminary report: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Report plan version 2.0: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Documentation and appraisal of comments on the report plan version 1.0: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Amendment 1 to the report plan version 1.0: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression

Report plan version 1.0: Selective serotonin and norepinephrine re-uptake inhibitors (SNRI) in the treatment of depression